ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1285–1296 of 2020 project topics
Multi-Gene Pharmacogenomic Panel SaaS Platform
A cloud-based diagnostic platform that integrates genetic data from multiple drug-metabolizing genes to generate comprehensive pharmacogenomic reports for clinical labs and hospitals. This software-as-a-service model creates recurring revenue through subscription licensing while reducing per-test operational costs for healthcare providers.
Genetics of Drug Metabolism and Transport Click to view more details →
Personalized Drug Dosing Algorithm and Clinical Decision Support
A machine learning-powered tool that translates genetic profiles into actionable dosing recommendations for precision medicine practitioners and pharmacy chains. The platform generates revenue through licensing agreements with hospital networks and pharmaceutical benefit managers seeking to optimize medication efficacy and reduce adverse events.
Genetics of Drug Metabolism and Transport Click to view more details →
Population Pharmacogenetics Database and Analytics Suite
A comprehensive, proprietary database aggregating pharmacogenetic variation data across diverse populations with advanced analytics for identifying treatment-response patterns. The platform serves pharmaceutical companies and contract research organizations conducting drug development studies and pharmacoeconomic analyses, generating licensing and data access fees.
Genetics of Drug Metabolism and Transport Click to view more details →
Genetic Biomarker Testing Kit for Direct-to-Consumer Wellness
A consumer-focused genetic testing product that identifies individual drug metabolism profiles with personalized health and medication recommendations delivered through a mobile application. This business model generates revenue through direct sales, upsells for detailed clinical reports, and partnerships with insurance providers and telehealth platforms.
Genetics of Drug Metabolism and Transport Click to view more details →
Clinical Laboratory Information Management System Integration
A LIMS integration tool that automates pharmacogenomic test ordering, result interpretation, and clinical reporting workflows within existing laboratory infrastructure. The platform delivers value through increased laboratory throughput, reduced turnaround times, and improved billing accuracy, generating enterprise licensing and implementation service fees.
Genetics of Drug Metabolism and Transport Click to view more details →
Variant Interpretation Engine for Rare Drug-Gene Interactions
An AI-powered bioinformatics tool that predicts functional consequences of novel and rare genetic variants affecting drug metabolism and transport proteins using real-time genomic databases. The service generates revenue through API licensing to genetic testing companies, pharmaceutical manufacturers, and clinical research institutions requiring cutting-edge variant classification.
Genetics of Drug Metabolism and Transport Click to view more details →
FKTN Fukuyama CMD Gene Analysis
Characterizing FKTN retrotransposal insertion and other variants causing Fukuyama CMD in Japanese and non-Japanese patients.
Genetic Basis of Dystroglycanopathies Click to view more details →
POMT1 and POMT2 Walker-Warburg Syndrome Testing
Applying POMT1 and POMT2 gene sequencing for molecular diagnosis in the severe Walker-Warburg syndrome end of the dystroglycanopathy spectrum.
Genetic Basis of Dystroglycanopathies Click to view more details →
LGMD With Brain Involvement Gene Panel
Developing panels for LGMD subtypes with brain abnormalities covering dystroglycanopathy genes for molecular classification and genotype-phenotype correlation.
Genetic Basis of Dystroglycanopathies Click to view more details →
Novel Dystroglycanopathy Gene Identification
Using WES for identifying novel O-mannosylation pathway gene mutations in patients with CMD and brain abnormalities without mutations in known genes.
Genetic Basis of Dystroglycanopathies Click to view more details →
ISPD Gene Mutation Detection Platform for CMD Diagnosis
A cloud-based SaaS platform that sequences and analyzes ISPD gene mutations to rapidly diagnose congenital muscular dystrophy in clinical settings. This tool enables laboratories to offer faster turnaround diagnostics, reducing time-to-treatment and creating recurring subscription revenue through per-sample analysis fees.
Genetic Basis of Dystroglycanopathies Click to view more details →
DAG1 Protein Glycosylation Commercial Assay Kit
A high-throughput diagnostic assay kit that measures DAG1 glycosylation defects to stratify dystroglycanopathy patients for targeted therapeutic interventions. This product generates immediate sales revenue and establishes market position in the precision diagnostics space for rare neuromuscular disorders.
Genetic Basis of Dystroglycanopathies Click to view more details →